Related Experiment Video
Updated: May 7, 2026

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
Published on: May 25, 2022
Human vaccines & immunotherapeutics: news
1Acquisitions Editor; Landes Bioscience; Vienna, Austria.
Vaccinating boys against the human papillomavirus (HPV) can lower cancer rates for everyone. New research explores advanced vaccine technologies, including marine sponge products and modular designs, to improve public health.
Area of Science:
- Immunology and Virology
- Biotechnology and Marine Natural Products
- Public Health and Epidemiology
Background:
- The abstract highlights diverse vaccine research, including HPV vaccination for boys to reduce cancer transmission, the use of marine sponge-derived compounds for melanoma vaccines, and the impact of Haemophilus influenzae type b (Hib) conjugate vaccines in developing nations.
- It also touches upon the integration of Electronic Health Records (EHRs) for tracking immunization status and the recommendation for pregnant women to receive the whooping cough vaccination.
Discussion:
- Innovations in vaccine technology are explored, such as a new nano-coating for vaccine preservation and an alternative approach to developing a universal influenza vaccine.
- Modular vaccine design and the Matrix-Antigen-Presentation-System (MAPS) technology are presented as novel strategies for vaccine development.
Key Insights:
- Expanding HPV vaccination to boys offers a strategy to reduce cancer incidence across all sexes.
- Natural products from marine sponges show potential in melanoma vaccine development.
- Hib conjugate vaccines have demonstrated significant public health impact in developing countries.
Outlook:
- Continued advancements in vaccine preservation, such as nano-coatings, are crucial for global vaccine efficacy.
- Modular vaccine design and technologies like MAPS offer promising avenues for creating next-generation vaccines, including universal influenza vaccines.
- Integrating EHRs and targeted vaccination campaigns (e.g., for pregnant women) are essential for optimizing immunization coverage and public health outcomes.
More Related Videos
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Vaccinations
Vaccines
Tumor Immunotherapy
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...